CD36 Antigens: Clinical Trials

2 trials of CD36 Antigens, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 1, Recruiting 1

Follow CD36 Antigens: new trials by email Literature Review of CD36 Antigens trials Research Report on CD36 Antigens

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Investigating the Pharmacokinetics of Tafenoquine in Healthy Papua New Guinean Children
Single dose tafenoquine (10 mg/kg) given with water, Single dose tafenoquine (10 mg/kg) given with fat - Pharmacokinetics of Tafenoquine
Phase 4RecruitingCurtin University302025-10-202026-03-18
Orlistat (Xenical) in the Treatment of Overweight Patients With Nonalcoholic Steatohepatitis (NASH)
Orlistat (Xenical), 1400 kcal diet (30% fat) - Fatty Liver, Hepatitis
Phase 4CompletedSt. Louis University502003-10-012007-11-20

Conditions studied

Fatty Liver (1)  ·  Hepatitis (1)  ·  Insulin Resistance (1)  ·  Malaria, Vivax (1)  ·  Non-alcoholic Fatty Liver Disease (1)  ·  Obesity (1)

Sponsors

Curtin University (1)  ·  St. Louis University (1)

Countries

Papua New Guinea (1)  ·  United States (1)

Top investigators

Brent A Tetri, MD (1)  ·  Brioni R Moore, PhD (1)

Results publications

PMID 19053049